Medical devices, healthcare technology and the business of care
510(k) clearance · K262637

SLIT LAMP SL-D4 (Type: LED)

Topcon Corporation · Decision date Sep 18, 2026

MEDTECHLEDGER EXPLANATIONK262637

What did the FDA decide?

Topcon Corporation received a substantially equivalent (SESE) decision for the SLIT LAMP SL-D4 (Type: LED) under 510(k) K262637, dated September 18, 2026, with the application received July 29, 2026. The device is a Class II AC-powered slitlamp biomicroscope under 21 CFR 886.1850, product code HJO, in the Ophthalmic specialty. This is a clearance, not a PMA approval.

The submission identifies the Slit Lamp SL-D701 (K133667), also held by Topcon, as the predicate. The summary states the intended use, operating principle and technological characteristics are similar or equivalent, and lists non-clinical testing against ANSI AAMI ES60601-1, IEC 60601-1-2, ISO 15004-1, ANSI Z80.36 and ANSI Z80.37. The record does not include clinical performance data, and the summary's 510(k) number field for the subject device reads "Not yet known."

Regulatory pathway
510(k) premarket notification
Clinical specialty
Ophthalmic
Decision date
Sep 18, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262637
Regulatory pathway
510(k) premarket notification
Product code
HJO
Decision code
SESE
Decision date
Sep 18, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Biomicroscope, Slit-Lamp, Ac-Powered.

Product code
HJO
FDA device class
2

FDA decision timeline

  1. K262637 received

    Application receipt date recorded by FDA.

  2. K262637 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Topcon Corporation

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Tokyo

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records